FDA.reportPublic FDA data

nintedanib 150 MG Oral Capsule [Ofev]

RxCUI
1592752
RxNorm name
nintedanib 150 MG Oral Capsule [Ofev]
Display name
nintedanib 150 MG Oral Capsule [Ofev]
Full name
nintedanib 150 MG Oral Capsule [Ofev]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OfevNINTEDANIBBoehringer Ingelheim Pharmaceuticals, Inc.da1c9f37-779e-4682-816f-93d0faa4cfc92025-11-20Warnings, Adverse reactionsExact identifier
rxcui: 1592752

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da1c9f37-779e-4682-816f-93d0faa4cfc9Ofev 150 MG Oral Capsule [PSN] · nintedanib 150 MG Oral Capsule [Ofev] [SBD] · Ofev 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule [SY]321These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 201420251120